Transfusing children with hemoglobinopathies.
Drépanocytose
Gene therapy
Greffe de cellules souches hématopoïétiques
Hematopoietic stem cell transplantation
Hydroxyurea
Hydroxyurée
Red blood cell transfusion
Sickle cell disease
Thalassemia
Thalassémie
Thérapie génique
Transfusion érythrocytaire
Journal
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine
ISSN: 1953-8022
Titre abrégé: Transfus Clin Biol
Pays: France
ID NLM: 9423846
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
25
06
2019
accepted:
25
06
2019
pubmed:
14
7
2019
medline:
18
2
2020
entrez:
14
7
2019
Statut:
ppublish
Résumé
Thalassemia and sickle cell disease (SCD) are among the most common inherited diseases worldwide. Red blood cell transfusion is a cornerstone of their treatment, but its indications have significantly changed over the past years. New therapies are emerging in both syndromes: among them, hematopoietic stem cell transplantation is now routinely proposed, and gene therapy has shown promising preliminary results.
Identifiants
pubmed: 31300265
pii: S1246-7820(19)30388-X
doi: 10.1016/j.tracli.2019.06.323
pii:
doi:
Substances chimiques
Hydroxyurea
X6Q56QN5QC
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
147-149Informations de copyright
Copyright © 2019. Published by Elsevier Masson SAS.